MedPath

Evaluation of the improving effects on liver function, status of fatigue, mood, and sleep after ingestion of the supplement

Not Applicable
Conditions
Healthy adult
Registration Number
JPRN-UMIN000044415
Lead Sponsor
EP Mediate Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
44
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Subjects who ALT levels >= 51 U / L or AST levels >= 51 U / L or gamma-GTP levels >= 101 U / L on the preliminary examination (2) Subjects who are positive for HCV antibody or HbsAg on the preliminary examination (3) Subjects who cannot accomplish the intact inspection procedure as prescribed (4) Subjects who are judged as unsuitable for the study based on the results of the lifestyle questionnaire (5) Subjects who constantly use health food richly containing involvement ingredient (6) Subjects who constantly use supplements or drugs affecting the liver function (7) Subjects who constantly use supplements or drugs affecting the status of fatigue, mood, and sleep (8) Subjects who have serious illnesses such as diabetes, liver disease, kidney disease, heart disease, and cancer or history of those illnesses (9) Subjects having possibilities for emerging allergy related to the study (10) Subjects having a disease requiring treatment or a history of serious diseases for which medication was required (11) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination (12) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study (13) Subjects who intend to become pregnant or lactating during the test period (14) Subjects who habitually do intense exercise such as marathon. (15) Subjects who take constant or frequent night shifts (16) Subjects judged as unsuitable for the study by the principle investigator for other reasons

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath